Figure 3
Effect of PEMF on osteoblast-relavant genes in human BMSCs. Gene expression ratios of selected genes plotted as expression in PEMF-treated condition relative to non-treated control. Targeted genes are A) bone morphogenetic protein 2 (BMP-2); B) transforming growth factor beta 1 (TGF-β1); C) osteoprotegrin (OPG); D) receptor activator of NF-kappa-B ligand (RANKL); E) matrix metalloproteinase 1 (MMP-1); F) matrix metalloproteinase 3 (MMP-3). Significant differences due to PEMF are marked * (p < 0.05), n = 4.